Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
3(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
11%
Ph not_applicable
3
33%
Ph phase_3
1
11%
Ph phase_4
2
22%
Ph phase_2
2
22%

Phase Distribution

1

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
2(22.2%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
2(22.2%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(4)
Completed(3)
Other(2)

Detailed Status

Completed3
Active, not recruiting2
unknown2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 22 (22.2%)
Phase 31 (11.1%)
Phase 42 (22.2%)
N/A3 (33.3%)

Trials by Status

active_not_recruiting222%
recruiting111%
completed333%
unknown222%
not_yet_recruiting111%

Recent Activity

3 active trials
Showing 5 of 9
active_not_recruitingphase_2

Terazosin Effect on Cardiac Changes in Early Parkinson's Disease

NCT04386317
recruitingphase_3

Comparison of Alpha Blockers (Terazosin and Tamsulosin) in Reducing Ureteral Stent Related Symptoms

NCT06966804
active_not_recruitingphase_1

Target Engagement of Terazosin in Healthy Adults

NCT04551040
not_yet_recruitingphase_4

Motor Function Efficacy of Pharmacological Treatments Targeting Energy Metabolism, in Parkinson's Patients

NCT05855577
unknownphase_2

Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting

NCT03195673
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT04386317Phase 2

Terazosin Effect on Cardiac Changes in Early Parkinson's Disease

Active Not Recruiting
NCT06966804Phase 3

Comparison of Alpha Blockers (Terazosin and Tamsulosin) in Reducing Ureteral Stent Related Symptoms

Recruiting
NCT04551040Phase 1

Target Engagement of Terazosin in Healthy Adults

Active Not Recruiting
NCT05855577Phase 4

Motor Function Efficacy of Pharmacological Treatments Targeting Energy Metabolism, in Parkinson's Patients

Not Yet Recruiting
NCT03195673Phase 2

Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting

Unknown
NCT00449683Phase 4

Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Terazosin

Completed
NCT01508637Not Applicable

Diesel Exhaust and Vascular Function

Unknown
NCT00237510Not Applicable

Pilot Study of Terazosin in Treatment of Antidepressant Induced Excessive Sweating

Completed
NCT00693199Not Applicable

Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and Hypertension

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9